Literature DB >> 7513313

Penner's serotype 4 of Campylobacter jejuni has a lipopolysaccharide that bears a GM1 ganglioside epitope as well as one that bears a GD1 a epitope.

N Yuki1, T Taki, M Takahashi, K Saito, T Tai, T Miyatake, S Handa.   

Abstract

The carbohydrate structures of lipopolysaccharides (LPSs) of Campylobacter jejuni strains belonging to Penner's serotypes (PEN) 1, 2, 4, 19, 23, and 36 were studied by thin-layer chromatography and immunostaining with several monoclonal antiganglioside antibodies. Anti-GM1 and anti-GD1a antibodies reacted with the LPSs of PEN 1, 4, and 19. Aspinall et al. (G. O. Aspinall, A. G. McDonald, T. S. Raju, H. Pang, A. P. Moran, and J. L. Penner. Eur. J. Biochem. 213:1017-1027, 1993) recently reported that the LPS of PEN 4 has a GD1a ganglioside-like structure rather than a GM1-like structure. We found that the LPS fraction of C. jejuni (PEN 4) has an LPS that bears a GM1 epitope as well as an LPS that bears a GD1a epitope.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7513313      PMCID: PMC186473          DOI: 10.1128/iai.62.5.2101-2103.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  HLA-B35 and acute axonal polyneuropathy following Campylobacter infection.

Authors:  N Yuki; S Sato; T Itoh; T Miyatake
Journal:  Neurology       Date:  1991-10       Impact factor: 9.910

Review 2.  The genus Campylobacter: a decade of progress.

Authors:  J L Penner
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

3.  Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis.

Authors:  N Yuki; H Yoshino; S Sato; T Miyatake
Journal:  Neurology       Date:  1990-12       Impact factor: 9.910

4.  Guillain-Barré syndrome associated with high titers of anti-GM1 antibodies.

Authors:  E Nobile-Orazio; M Carpo; N Meucci; M P Grassi; E Capitani; M Sciacco; A Mangoni; G Scarlato
Journal:  J Neurol Sci       Date:  1992-06       Impact factor: 3.181

Review 5.  [An acute axonal polyneuropathy affecting intrinsic hand muscles following Campylobacter infection--a case report].

Authors:  M Oyake; K Miyashita; N Yuki; T Yuasa; T Miyatake
Journal:  Rinsho Shinkeigaku       Date:  1992-03

6.  Generation of one set of monoclonal antibodies specific for a-pathway ganglio-series gangliosides.

Authors:  M Kotani; H Ozawa; I Kawashima; S Ando; T Tai
Journal:  Biochim Biophys Acta       Date:  1992-07-21

7.  Serological diversity and chemical structures of Campylobacter jejuni low-molecular-weight lipopolysaccharides.

Authors:  G O Aspinall; A G McDonald; T S Raju; H Pang; S D Mills; L A Kurjanczyk; J L Penner
Journal:  J Bacteriol       Date:  1992-02       Impact factor: 3.490

8.  Generation of one set of monoclonal antibodies specific for b-pathway ganglio-series gangliosides.

Authors:  H Ozawa; M Kotani; I Kawashima; T Tai
Journal:  Biochim Biophys Acta       Date:  1992-01-24

9.  A new monoclonal antibody directed to sialyl alpha 2-3lactoneotetraosylceramide and its application for detection of human gastrointestinal neoplasms.

Authors:  Y Suzuki; H Nishi; K Hidari; Y Hirabayashi; M Matsumoto; T Kobayashi; S Watarai; T Yasuda; J Nakayama; H Maeda
Journal:  J Biochem       Date:  1991-02       Impact factor: 3.387

10.  A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure.

Authors:  N Yuki; T Taki; F Inagaki; T Kasama; M Takahashi; K Saito; S Handa; T Miyatake
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

View more
  23 in total

1.  Preceding infections and anti-ganglioside antibody profiles assessed by a dot immunoassay in 306 French Guillain-Barré syndrome patients.

Authors:  Christiane Caudie; Arnaud Quittard Pinon; Didier Taravel; Valérie Sivadon-Tardy; David Orlikowski; Flore Rozenberg; Tarek Sharshar; Jean Claude Raphaël; Jean Louis Gaillard
Journal:  J Neurol       Date:  2011-04-24       Impact factor: 4.849

Review 2.  Ganglioside molecular mimicry and its pathological roles in Guillain-Barré syndrome and related diseases.

Authors:  Robert K Yu; Seigo Usuki; Toshio Ariga
Journal:  Infect Immun       Date:  2006-09-11       Impact factor: 3.441

3.  Serum antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in Miller Fisher syndrome.

Authors:  A Neisser; H Bernheimer; T Berger; A P Moran; B Schwerer
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

Review 4.  Autoimmune responses in peripheral nerve.

Authors:  H P Hartung; H Willison; S Jung; M Pette; K V Toyka; G Giegerich
Journal:  Springer Semin Immunopathol       Date:  1996

5.  Epidemiology of peripheral neuropathy.

Authors:  C N Martyn; R A Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-04       Impact factor: 10.154

6.  Immunoglobulin KM allotypes are associated with the prevalence of autoantibodies to GD1a ganglioside, but not with susceptibility to the disease, in Japanese patients with Guillain-Barré syndrome.

Authors:  Janardan P Pandey; Michiaki Koga; Nobuhiro Yuki
Journal:  Neurogenetics       Date:  2005-10-29       Impact factor: 2.660

7.  Isolation and characterisation of T lymphocytes from sural nerve biopsies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.

Authors:  A Ben-Smith; J S Gaston; P C Barber; J B Winer
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-10       Impact factor: 10.154

Review 8.  The role of infections in autoimmune disease.

Authors:  A M Ercolini; S D Miller
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

9.  Identification of the enteropathogens Campylobacter jejuni and Campylobacter coli based on the cadF virulence gene and its product.

Authors:  M E Konkel; S A Gray; B J Kim; S G Garvis; J Yoon
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

10.  Microtiter assay for detecting Campylobacter spp. and Helicobacter pylori with surface gangliosides which bind cholera toxin.

Authors:  D A Sack; A J Lastovica; S H Chang; G Pazzaglia
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.